Navigation Links
Scientists Gather to Discuss Novel Uses of Caliper Life Sciences' Discovery Platforms and Technology
Date:6/29/2009

- Recent 'Innovation for Experimentation' Series Attracts Over 350 Attendees -

HOPKINTON, Mass., June 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, reports that more than 350 customers recently attended its "Innovation for Experimentation" seminar series and open house events held in California and Massachusetts. The seminar series showcased how customers were successfully deploying technologies from Caliper to accelerate drug discovery research.

The events were held in San Francisco, San Diego and Hopkinton to discuss the importance of Caliper's automation, microfluidics, and in vivo imaging technologies. Key themes included approaches for obtaining higher fidelity data that better predict human outcomes, increasing throughput and unattended run time while being cognizant of optimizing higher order workflows, decentralizing testing to ensure information is available in real time to decision makers, and increasing the knowledge generated per dollar, hour, and number of samples.

"The life sciences industry is tasked with the noble mission of finding cures and treatments for the sick and suffering," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Our symposium series 'Innovation for Experimentation' enables us to better align our internal research priorities and investments with customer requirements to ensure that we develop technologies that enable our customers to be successful in increasing the quality and length of life. This year's series was the best attended in years primarily due to our new comprehensive suite of 'breakthrough' LabChip, IVIS and Zephyr platforms."

The events featured customer presentations focused on the adoption of Caliper platforms to accelerate discovery research at the following institutions: Pfizer, Merck, EMD Serono, Amgen, ArQule, Dana Farber Cancer Institute, Boehringer-Ingelheim, Wyeth, Calloway Labs, University of Massachusetts, Genencor, Bristol-Myers Squibb, XcellereX, SUNY Upstate, Vertex, Dow Biopharma, Symbiosis, MacroGenics, Geron, Elan, Roche, and the National Cancer Institute. The open house event in Hopkinton featured a keynote presentation from Kevin Hrusovsky, which is available online: http://www.caliperls.com/investors/open-house-061909-ceo-presentation.php.

Investors and analysts were also invited to attend and participate in a separate breakout session featuring presentations by Kevin Hrusovsky, President and CEO, as well as several members of Caliper's executive team, who outlined Caliper's strategic priorities and the future direction of Caliper's technologies and services. A webcast of this breakout session is available online: http://phx.corporate-ir.net/phoenix.zhtml?c=85833&p=irol-EventDetails&EventId=2268770.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, IVIS, and Zephyr are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: